Brain & Behavior Research Foundation International Mental Health Research Symposium Featuring Talks on Psychosis, Child and Adolescent Psychiatry, Mood Disorders and More
17. Oktober 2024 11:19 ET
|
Brain & Behavior Research Foundation
New York, Oct. 17, 2024 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) International Mental Health Research Symposium will be held on Friday, October 25, 2024, at the...
When Medicine is Not Enough for Schizophrenia and Psychosis
30. Juni 2022 09:00 ET
|
Brain & Behavior Research Foundation
New York, June 30, 2022 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “When Medicine is Not Enough for Schizophrenia and Psychosis” on Tuesday,...
Cognitive Impairment in Psychosis: What it is and How it's Treated - A Free Webinar from the Brain & Behavior Research Foundation
08. Juli 2021 09:00 ET
|
Brain & Behavior Research Foundation
New York, July 08, 2021 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Cognitive Impairment in Psychosis: What it is and How it's Treated” on...
AXIM Biotech Enters Clinical Study Agreement with University of British Columbia to Begin Clinical Trial On CBD Chewing Gum For Treatment of Drug-Related Psychosis
02. August 2017 09:00 ET
|
AXIM Biotechnologies, Inc
NEW YORK, Aug. 02, 2017 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that it has entered into a...
AXIM Biotech Advisory Board Member Presented at CannMed 2017 Personalized Cannabinoid Medicine Conference at Harvard
13. April 2017 09:00 ET
|
AXIM Biotechnologies, Inc
NEW YORK, April 13, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that Dr. Ilya Reznik, a...
Access to Cannabis Should Not Occur Prior to Age 21, according to a position statement by the Canadian Consortium for Early Intervention in Psychosis
02. Februar 2017 13:33 ET
|
Canadian Consortium for Early Intervention in Psychosis
HAMILTON, Ontario, Feb. 02, 2017 (GLOBE NEWSWIRE) -- In response to the recommendations of the Task Force on Marijuana Legalization and Regulation, the Canadian Consortium for Early Intervention in...